• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Up and down the ladder: The latest comings and goings - 2 day(s) ago

      From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? https://t.co/qyeXC4PVZy #pharma #biotech #jobs #Pfizer #JNJ #GSK #Bayer $PFE $GSK $JNJ $GMAB $JAZZ

    • Mashup Score: 1
      Pharmalittle: We're reading about a FDA offer on drug reviews, a Moderna Covid approval, and more - 2 day(s) ago

      FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U.S. and other countries

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a FDA offer on drug reviews, a Moderna Covid approval & more news.. https://t.co/UY0pFmwoSU #pharma #Zantac #Covid #vaccines #FDA #Duchenne #epilepsy $PFE $SNY $MRNA $GSK $CAPR $JAZZ

    • Mashup Score: 4
      Pharmalittle: We're reading about Regeneron's patent maneuvers, FDA rejection letters, and lots more - 3 day(s) ago

      A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to thwart competition

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters & lots more news.. https://t.co/xyQF5RiZMI #pharma #Covid #vaccines #patents #biosimilars #weight #obesity #abortion #advertising #eyes #humanrights $REGN $AMGN $PFE

    • Mashup Score: 3
      How Regeneron, maker of a best-selling eye drug, is using patent tactics to try to thwart competition - 4 day(s) ago

      A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using patents to thwart competition.

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        How Regeneron, maker of a best-selling eye drug, is using patent tactics to try to thwart competition.. https://t.co/kPkNtYYdsj #pharma #biotech #patents #eylea #Regeneron #Amgen $REGN $AMGN

    • Mashup Score: 1
      Pharmalittle: We're reading about Trump's latest tariff threat, a Merck deal, and lots more - 4 day(s) ago

      President Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S., but not immediately

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump’s latest tariff threat, a Merck deal & lots more news.. https://t.co/UvjFvCbR9X #pharma #Trump #tariffs #Alzheimer #Medicare #Medicaid #weight #obesity #Wegovy #HIV #biosimilars $MRK $NVO $LLY $GILD $CVS

    • Mashup Score: 1
      Pharmalittle: We're reading about Medicare drug negotiations, a Novartis malaria drug, and more - 5 day(s) ago

      The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug price negotiations

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Medicare drug negotiations, a Novartis malaria drug & more news.. https://t.co/lRAKKx1U1Q #pharma #RFKJr #FDA #NIH #HHS #PBM #Animals #Trump #Medicare #malaria #Covid #NVS $CVS $UNH $CI

    • Mashup Score: 0
      Pharmalittle: We're reading about FDA morale, a U.S.-Swiss trade deal on pharma levies, and more - 6 day(s) ago

      The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Pharmalot.. Pharmalittle.. Good Morning: We’re reading about FDA morale, a U.S.-Swiss trade deal on pharma levies & more news.. https://t.co/hdnYkDkaL5 #pharma #Trump #tariffs #Switzerland #China #UK #antitrust #FDA $KALV $NVS $RHHBY

    • Mashup Score: 2
      Pharmalittle: We're reading about FDA forcing out top gene therapy regulator, Gilead's HIV challenges and more - 23 day(s) ago

      And more pharma news updates from Pharmalittle.

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Pharmalot.. Pharmalittle.. Good Morning: We’re reading about FDA forcing out top gene therapy regulator, Gilead’s HIV challenges & more news. https://t.co/PGPahxdZJc #pharma #biotech #weight #obesity #Trump #tariffs #China #UK #skin #Ireland #HIV #AIDS $GILD $LLY $BIIB $SNY $REGN

    • Mashup Score: 3
      Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access? - 25 day(s) ago

      Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income countries gain access?

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access?.. https://t.co/YMzHslaAMY #AIDS #HIV #pharma #biotech #infectiousdisease #medicine #prevention #access #Gilead

    • Mashup Score: 3
      Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access? - 25 day(s) ago

      Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income countries gain access?

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access?.. https://t.co/YMzHslaAMY #AIDS #HIV #pharma #biotech #infectiousdisease #medicine #prevention #access #Gilead

    Load More

    pharmalot

    @pharmalot

    The latest news and views about the pharmaceutical industry, with @EdSilverman of @Statnews, ex-WSJ

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings